FATTY LIVER
Clinical trials for FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER trials appear
Sign up with your email to follow new studies for FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight-Loss drug may curb alcohol cravings in fatty liver patients
Disease control Not yet recruitingThis study tests whether semaglutide (a GLP-1 drug used for diabetes and weight loss) can help people with obesity and fatty liver disease stop drinking alcohol. About 64 participants will receive either semaglutide or a placebo, plus counseling, for 16 weeks. The main goal is to…
Matched conditions: FATTY LIVER
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Zapping the brain to heal the liver: a new hope for MetALD?
Disease control Not yet recruitingThis study tests if a non-invasive brain stimulation technique called rTMS can reduce liver fat in people with MetALD, a liver disease linked to both alcohol and metabolic issues. 105 adults will be randomly assigned to receive personalized rTMS, standard rTMS, or a sham (placebo…
Matched conditions: FATTY LIVER
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New ultrasound test could replace liver biopsies for fatty liver patients
Knowledge-focused Not yet recruitingThis study looks at two different ultrasound machines to see if they can accurately measure liver stiffness and inflammation in people with fatty liver disease. About 95 to 100 adults will take part, including some healthy volunteers. The goal is to find a non-invasive way to tel…
Matched conditions: FATTY LIVER
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 07:05 UTC